Good afternoon, and thank you for joining us for our fourth quarter 2025 earnings call and business update. Joining me today ...

Thank you, Jenny, and thank you all for joining us today. The strength of the company's stem cell science and success in multiple clinical trials across several indications positions Longeveron to be ...

Q4 2025 Management View Jennifer Good, CEO, reported that "2025 was a major inflection point for growth at Trevi, driven by our positive data readouts in both the CORAL trial in patients with ...

I'm joined by Todd Yoder, Shimmick CFO. Before I get started, I would like to recognize the women and men who work at Shimmick, safely and effectively delivering the projects we take on as good ...

Thank you, Hilla, and welcome to IceCure Medical Ltd's conference call to review the financial results as of and for the twelve months ended December 31, 2025, and provide an update on recent ...

Historian Thomas Zimmer says Trump is still dangerous, but that his authoritarian project has been derailed on a number of fronts.

Alicia Collymore discusses the critical role of cultural alignment in building high-performing engineering teams. She explains how to move beyond "vibes" by identifying specific attributes in company ...

Nektar Therapeutics (NASDAQ:NKTR) Q4 2025 Earnings Call Transcript March 12, 2026 Nektar Therapeutics beats earnings expectations. Reported EPS is $-1.77756, expectations were $-2.47411. Operator: ...

During a press conference at THE PLAYERS, PGA TOUR CEO Brian Rolapp discussed potential schedule changes, field sizes, ...

Nuwellis, Inc. beats earnings expectations. Reported EPS is $-1.4998, expectations were $-1.56. Operator: Thank you for your continued patience. Your meeting will begin shortly. If you need assistance ...

In this episode, Rhea Kelly and Sean McDonald dive into leadership strategies in higher education IT. They discuss defining leadership, the major challenges for leaders today, including complexity and ...